NEWS
Clinical study demonstrates that Cardiola’s m.pulse® system “immediately improves cardiac output under acute non-invasive Muscular CounterPulsation (MCP) treatment in patients with patients with stable CHF” (chronic heart failure)
Data presented at annual congress of the German Society of Cardiology
read more...
Cardiola collaborates with leading German cardiac center in study of its Muscular CounterPulsation (MCP)-based m.pulse® system for non-surgically treating chronic heart failure patients at home
First 20 patients with early-stage (NYHA > II) CHF have been enrolled
read more...
Cardiola raises $4 million from existing and new investors
Cardiola penetrates European market with its Muscular CounterPulsation (MCP)-based m.pulse® system